Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Risk factors for arteriosclerosis].

C Henzen1

  • 1Medizinische Klinik, Kantonsspital, Luzern. christoph.henzen@ksl.ch

Praxis
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Arteriosclerotic damage stems from dyslipidemia, hypertension, diabetes mellitus, and smoking, major causes of vascular disease. Controlling these risk factors significantly reduces mortality and complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nutritional support during the hospital stay reduces mortality in patients with different types of cancers: secondary analysis of a prospective randomized trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Secondary prevention of minor trauma fractures: the effects of a tailored intervention-an observational study.

Archives of osteoporosis·2019
Same author

Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptoms.

Journal of endocrinological investigation·2016
Same author

Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up study.

Journal of internal medicine·2014
Same author

[Endocrinologic side effects of oncologic treatment with anti-CTLA-4-antibodies].

Deutsche medizinische Wochenschrift (1946)·2014
Same author

[Hypoclycaemia in a diabetic man's wife].

Therapeutische Umschau. Revue therapeutique·2012
Same journal

Praxis·2026
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
See all related articles

Area of Science:

  • Cardiovascular Science
  • Endothelial Biology
  • Risk Factor Analysis

Context:

  • Arteriosclerotic damage to the arterial endothelium is a primary driver of vascular morbidity and mortality.
  • Key initiating risk factors include dyslipidemia, hypertension, diabetes mellitus, and smoking.
  • Emerging risk factors are continually being identified, enhancing our understanding of atherogenesis.

Purpose:

  • To summarize the established and emerging risk factors for arteriosclerotic damage.
  • To highlight the impact of hyperlipidemia, hypertension, and diabetes mellitus on vascular health.
  • To underscore the role of smoking in peripheral arterial disease and arterial lesion progression.

Summary:

  • Dyslipidemia, particularly modified LDL-cholesterol, is confirmed as causative in hyperlipidemia.

Related Experiment Videos

  • Hypertension is a significant risk factor, with blood pressure reduction correlating to fewer vascular complications.
  • Diabetes mellitus reduces life expectancy due to cardiovascular disease, but intensive glucose and blood pressure control mitigate risks.

    • Impact:

    • Understanding these risk factors is crucial for preventing vascular morbidity and mortality.
    • Interventional studies validate the impact of managing hyperlipidemia, hypertension, and diabetes.
    • Identifying novel risk factors contributes to a more comprehensive approach to combating atherosclerosis.